CRESCENT CAPITAL BDC INC (CCAP) Stock Fundamental Analysis
USA - NASDAQ:CCAP - US2256551092 - Common Stock
15.73 USD
+0.04 (+0.25%)
15.73 USD
0 (0%)
We assign a fundamental rating of 3 out of 10 to CCAP. CCAP was compared to 236 industry peers in the Capital Markets industry. While CCAP is still in line with the averages on profitability rating, there are concerns on its financial health. CCAP has a valuation in line with the averages, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year CCAP was profitable.
CCAP had a positive operating cash flow in the past year.
In the past 5 years CCAP has always been profitable.
The reported operating cash flow has been mixed in the past 5 years: CCAP reported negative operating cash flow in multiple years.
1.2 Ratios
CCAP has a Return On Assets (2.67%) which is comparable to the rest of the industry.
CCAP's Return On Equity of 6.10% is in line compared to the rest of the industry. CCAP outperforms 41.95% of its industry peers.
Looking at the Return On Invested Capital, with a value of 3.87%, CCAP is in line with its industry, outperforming 51.69% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.67% | ||
| ROE | 6.1% | ||
| ROIC | 3.87% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
CCAP's Profit Margin of 24.12% is fine compared to the rest of the industry. CCAP outperforms 62.71% of its industry peers.
In the last couple of years the Profit Margin of CCAP has declined.
CCAP has a better Operating Margin (43.23%) than 77.12% of its industry peers.
In the last couple of years the Operating Margin of CCAP has declined.
With a Gross Margin value of 45.26%, CCAP perfoms like the industry average, outperforming 43.64% of the companies in the same industry.
In the last couple of years the Gross Margin of CCAP has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 43.23% | ||
| PM (TTM) | 24.12% | ||
| GM | 45.26% |
OM growth 3Y-4.73%
OM growth 5Y-5.04%
PM growth 3Y-25.14%
PM growth 5Y-7.39%
GM growth 3Y-5.55%
GM growth 5Y-5.93%
2. Health
2.1 Basic Checks
CCAP has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
Based on the Altman-Z score of 0.44, we must say that CCAP is in the distress zone and has some risk of bankruptcy.
CCAP has a Altman-Z score of 0.44. This is in the lower half of the industry: CCAP underperforms 62.71% of its industry peers.
CCAP has a debt to FCF ratio of 13.58. This is a negative value and a sign of low solvency as CCAP would need 13.58 years to pay back of all of its debts.
CCAP has a Debt to FCF ratio (13.58) which is in line with its industry peers.
A Debt/Equity ratio of 1.22 is on the high side and indicates that CCAP has dependencies on debt financing.
CCAP has a worse Debt to Equity ratio (1.22) than 61.86% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.22 | ||
| Debt/FCF | 13.58 | ||
| Altman-Z | 0.44 |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
A Current Ratio of 0.61 indicates that CCAP may have some problems paying its short term obligations.
The Current ratio of CCAP (0.61) is worse than 72.03% of its industry peers.
A Quick Ratio of 0.61 indicates that CCAP may have some problems paying its short term obligations.
CCAP has a Quick ratio of 0.61. This is in the lower half of the industry: CCAP underperforms 72.03% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.61 | ||
| Quick Ratio | 0.61 |
3. Growth
3.1 Past
CCAP shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -17.65%.
The Earnings Per Share has been growing slightly by 7.26% on average over the past years.
The Revenue has decreased by -7.22% in the past year.
CCAP shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 29.83% yearly.
EPS 1Y (TTM)-17.65%
EPS 3Y10.16%
EPS 5Y7.26%
EPS Q2Q%-22.03%
Revenue 1Y (TTM)-7.22%
Revenue growth 3Y28.05%
Revenue growth 5Y29.83%
Sales Q2Q%-12.17%
3.2 Future
The Earnings Per Share is expected to decrease by -16.21% on average over the next years. This is quite bad
The Revenue is expected to decrease by -6.78% on average over the next years.
EPS Next Y-27.14%
EPS Next 2Y-13.65%
EPS Next 3Y-16.21%
EPS Next 5YN/A
Revenue Next Year-15.01%
Revenue Next 2Y-7.05%
Revenue Next 3Y-6.78%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 7.49 indicates a rather cheap valuation of CCAP.
Based on the Price/Earnings ratio, CCAP is valued cheaply inside the industry as 87.71% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of CCAP to the average of the S&P500 Index (27.38), we can say CCAP is valued rather cheaply.
The Price/Forward Earnings ratio is 8.31, which indicates a very decent valuation of CCAP.
84.75% of the companies in the same industry are more expensive than CCAP, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 22.86. CCAP is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.49 | ||
| Fwd PE | 8.31 |
4.2 Price Multiples
Based on the Price/Free Cash Flow ratio, CCAP is valued a bit cheaper than 75.42% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 8.92 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
CCAP's earnings are expected to decrease with -16.21% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)1.03
EPS Next 2Y-13.65%
EPS Next 3Y-16.21%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 10.71%, CCAP is a good candidate for dividend investing.
CCAP's Dividend Yield is a higher than the industry average which is at 8.21.
Compared to an average S&P500 Dividend Yield of 2.38, CCAP pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 10.71% |
5.2 History
CCAP has been paying a dividend for over 5 years, so it has already some track record.
CCAP has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years4
Div Non Decr Years4
5.3 Sustainability
CCAP pays out 162.76% of its income as dividend. This is not a sustainable payout ratio.
DP162.76%
EPS Next 2Y-13.65%
EPS Next 3Y-16.21%
15.73
+0.04 (+0.25%)
Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)
Earnings (Next)
Inst Owners49.48%
Inst Owner Change6.48%
Ins Owners1.14%
Ins Owner Change0.04%
Market Cap582.95M
Analysts85
Price Target17.34 (10.24%)
Short Float %0.48%
Short Ratio0.67
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 10.71% |
Yearly Dividend1.9
Dividend Growth(5Y)N/A
DP162.76%
Div Incr Years4
Div Non Decr Years4
Ex-Date
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-9.71%
Min EPS beat(2)-15.91%
Max EPS beat(2)-3.5%
EPS beat(4)1
Avg EPS beat(4)-3.56%
Min EPS beat(4)-15.91%
Max EPS beat(4)9.46%
EPS beat(8)4
Avg EPS beat(8)2.4%
EPS beat(12)7
Avg EPS beat(12)2.79%
EPS beat(16)10
Avg EPS beat(16)3.02%
Revenue beat(2)0
Avg Revenue beat(2)-4.62%
Min Revenue beat(2)-8.38%
Max Revenue beat(2)-0.86%
Revenue beat(4)1
Avg Revenue beat(4)-2.26%
Min Revenue beat(4)-8.38%
Max Revenue beat(4)3.96%
Revenue beat(8)5
Avg Revenue beat(8)-0.53%
Revenue beat(12)7
Avg Revenue beat(12)0.41%
Revenue beat(16)8
Avg Revenue beat(16)0.69%
PT rev (1m)-1.92%
PT rev (3m)-1.92%
EPS NQ rev (1m)1.45%
EPS NQ rev (3m)1.3%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.66%
Revenue NQ rev (1m)0.09%
Revenue NQ rev (3m)0.32%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.44%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.49 | ||
| Fwd PE | 8.31 | ||
| P/S | 3.18 | ||
| P/FCF | 8.92 | ||
| P/OCF | 8.92 | ||
| P/B | 0.8 | ||
| P/tB | 0.8 | ||
| EV/EBITDA | N/A |
EPS(TTM)2.1
EY13.35%
EPS(NY)1.89
Fwd EY12.04%
FCF(TTM)1.76
FCFY11.21%
OCF(TTM)1.76
OCFY11.21%
SpS4.94
BVpS19.56
TBVpS19.56
PEG (NY)N/A
PEG (5Y)1.03
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.67% | ||
| ROE | 6.1% | ||
| ROCE | 4.9% | ||
| ROIC | 3.87% | ||
| ROICexc | 3.9% | ||
| ROICexgc | 3.9% | ||
| OM | 43.23% | ||
| PM (TTM) | 24.12% | ||
| GM | 45.26% | ||
| FCFM | 35.68% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-4.73%
OM growth 5Y-5.04%
PM growth 3Y-25.14%
PM growth 5Y-7.39%
GM growth 3Y-5.55%
GM growth 5Y-5.93%
F-Score4
Asset Turnover0.11
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.22 | ||
| Debt/FCF | 13.58 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | 1.35 | ||
| Cash Conversion | N/A | ||
| Profit Quality | 147.94% | ||
| Current Ratio | 0.61 | ||
| Quick Ratio | 0.61 | ||
| Altman-Z | 0.44 |
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)123.47%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-17.65%
EPS 3Y10.16%
EPS 5Y7.26%
EPS Q2Q%-22.03%
EPS Next Y-27.14%
EPS Next 2Y-13.65%
EPS Next 3Y-16.21%
EPS Next 5YN/A
Revenue 1Y (TTM)-7.22%
Revenue growth 3Y28.05%
Revenue growth 5Y29.83%
Sales Q2Q%-12.17%
Revenue Next Year-15.01%
Revenue Next 2Y-7.05%
Revenue Next 3Y-6.78%
Revenue Next 5YN/A
EBIT growth 1Y-13.05%
EBIT growth 3Y21.99%
EBIT growth 5Y23.29%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y8.71%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y8.71%
OCF growth 3YN/A
OCF growth 5YN/A